This episode explores the critical shift for medical device manufacturers from using a distributor as their EU Authorized Representative (EC-REP) to appointing a professional, independent representative in France. We delve into the increased liabilities under the MDR, the inherent conflicts of interest in the distributor model, and the significant commercial and regulatory advantages of partnering with an independent AR for streamlined access to the French and broader EU markets. • Why is using a distributor as your EU Authorized Representative now considered a major risk? • What specific liabilities did the EU MDR place on Authorized Representatives? • How does an independent EC-REP provide greater market flexibility in France and across the EU? • What is the fundamental conflict of interest between a distributor's goals and an AR's duties? • What are the key steps involved in switching from a distributor to an independent AR? • How does this change affect your product labeling and registration? • Why is a formal transfer agreement essential for a smooth transition? • How can an independent AR improve your relationship with competent authorities like France's ANSM? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.